作者：
Denis A,Baird [1]
;
Jimmy Z,Liu [2]
;
Jie,Zheng [1]
;
Solveig K,Sieberts [3]
;
Thanneer,Perumal [3]
;
Benjamin,Elsworth [1]
;
Tom G,Richardson [1]
;
Chia-Yen,Chen [2]
;
Minerva M,Carrasquillo [4]
;
Mariet,Allen [4]
;
Joseph S,Reddy [5]
;
Philip L,De Jager [6]
;
Nilufer,Ertekin-Taner [7]
;
Lara M,Mangravite [3]
;
Ben,Logsdon [3]
;
Karol,Estrada [8]
;
Philip C,Haycock [1]
;
Gibran,Hemani [1]
;
Heiko,Runz [2]
;
George Davey,Smith [9]
;
Tom R,Gaunt [9]
;
AMP-AD eQTL working group
作者单位：
MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
[1]
Translational Biology, Research and Development, Cambridge, Massachusetts, United States of America.
[2]
Sage Bionetworks, Seattle, Washington, United States of America.
[3]
Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America.
[4]
Department of Health Sciences Research, Mayo Clinic Florida, Jacksonville, Florida, United States of America.
[5]
Centre for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Medical Centre, New York, New York, United States of America.;Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Centre, New York, New York, United States of America.
[6]
Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, United States of America.;Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, United States of America.
[7]
Translational Biology, Research and Development, Cambridge, Massachusetts, United States of America.;BioMarin Pharmaceuticals, San Rafael, California, United States of America.
[8]
MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.;NIHR Bristol Biomedical Research Centre, Oakfield House, University of Bristol, Bristol, United Kingdom.
[9]
DOI
10.1371/journal.pgen.1009224
PMID
33417599
发布时间
2024-08-05
换一批
换一批
